Association of Aromatase Inhibitors With Coronary Heart Disease in Women With Early Breast Cancer

Predictors and Temporal Trends of Adjuvant Aromatase Inhibitor Use in Breast Cancer

(2017) Tiffany H. Svahn et al.   Journal of the National Comprehensive Cancer Network

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

A Tale of Coronary Artery Disease and Myocardial Infarction

(2012) Elizabeth G. Nabel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aromatase Inhibition Attenuates Desflurane-Induced Preconditioning against Acute Myocardial Infarction in Male Mouse Heart In Vivo

(2012) Virginija Jazbutyte et al.   PLoS One

Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients

(2011) Jennifer A. Ligibel et al.   BREAST CANCER RESEARCH AND TREATMENT

Influence of Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the Arimidex, Tamoxifen Alone or in Combination Trial

(2011) Alistair Ring et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer

(2011) Allan Hackshaw et al.   JOURNAL OF CLINICAL ONCOLOGY

Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis

(2011) Eitan Amir et al.   JNCI-Journal of the National Cancer Institute

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

(2011) Paul E. Goss et al.   NEW ENGLAND JOURNAL OF MEDICINE

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

(2010) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial

(2009) Peter Collins et al.   CIRCULATION

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

(2009) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Trial Presentations, Agency Guidelines, and Oncology Practice: Findings from the Arimidex, Tamoxifen, Alone or in Combination Trial

(2008) Rowan T. Chlebowski   Clinical Breast Cancer